Atara Biotherapeutics Stock Falls After Surprise FDA Refusal to Approve Ebvallo
By Adriano Marchese Atara Biotherapeutics shares fell Monday after the company said the U.S. health regulator didn't approve its therapy, backtracking on its previous guidance. Shares fell...